Navigation Links
Replacement Bulb: HBO 50W/3

ProductsReplacement Bulb: HBO 50W/3
Company Bulb Direct, Inc.
Item Replacement Bulb: HBO 50W/3
Features 
Description Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discount light bulbs specials.

Check our web site for additional brands and prices.
Info Bulb Direct, Inc.
Customer Service: (800) 772-5267
Web site: http://www.bulbdirect.com/

Related medicine products :

1. Replacement Burr/Chuck
2. Replacement Burr
3. Replacement Burr Set
4. Replacement Needle Tip
5. Replacement Gouge Tip
6. Replacement Handle
7. Snare Wire Replacements for E3525 3/package
8. Healos Bone Graft Replacement
9. Verte-Span Vertebral Body Replacement
10. Vertebral Body Replacement (VBR)
11. Perfecta PDA Calcar Replacement Stems
The Omni-Flex System provides the capability to change frame arms in the middle of surgery while retaining exposure with tension on the incision. The system is also strong enough to be stable for lar
...actor System represents the most widely accepted "...array of retraction components provides numerous s...lti-directional exposure of the surgical field. In...pecific procedures: IMA Kit / Bariatric Kit / Spin...
...he Alexis Wound Retractor provides circumferential...ination. For open surgery, the Alexis Retractor pr...ion size. For laparoscopic surgery, the Alexis Ret...protection when an organ or specimen requires remo...
Pipetman Concept is a revolutionary motorized electronic pipette. Conceived with simplicity and flexibility in mind, Pipetman Concept features exclusive multifunction characteristics and a direct pip
Medicine Products:
(Date:10/7/2008)...uncement of planned bequest comes at stem cell sym...wswire/ -- Just over one year,ago, retail pioneer ...the,University of Michigan, to endow a new researc...reventing human disease., Today, at the institute...that he will bequeath an additional $22 million to...
(Date:10/7/2008)...0,000 PEOPLE ACROSS THE NATION HAVE SAID ,I VOTE F...ALLAS, Oct. 7 /PRNewswire/ -- To aid and help educ... the positions of presidential candidates,Senators...nd cancer issues,the Susan G. Komen for the Cure(...sources available on its web site --, http://www.I...
(Date:10/7/2008)... Wyndstorm Corporation ( www.wyndstorm.co...ia company, announced a key win with Muve, Inc. ( ...ing plan program design to promote Muve,s activity...ign project will ultimately help Muve,s corporate ...employees via interactive messaging, rewards progr...
(Date:10/7/2008)... means better access, more choices for Indiana hea...FORT WAYNE, Ind., Oct. 7 /PRNewswire/ -- Lutheran ...ement to partner with Consumers Life Insurance,Com...ervice to consumers in,12 Indiana counties includi...ork partnership is Fort Wayne,s Lutheran,Hospital,...
Breaking Medicine News(10 mins):Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 3Health News:Consumers Life Expands Healthcare Network in Northeast Indiana 2
...ers at the University of Michigan C.S. Mott Childr...are at an increased// risk for influenza-related c...e flu, even when they visit their doctor during fl... Archives of Pediatric and Adolescent Medicine, th...
...national team of researchers is developing a new g...between donors and recipients//. The Bloodchip giv...sts. The current tests look for blood types while ...es”. A spokeswoman for the National Blood Service...
...ican Physical Therapy Association (APTA) has said ... part of workplace injuries. It is a repetitive-st...of the popular BlackBerry devices. "The use of PD... longer limited to the eight hours spent in the wo...
...ionel Richie was so fearful over his daughter Nico...r to the doctors personally and find out the probl...cared for his daughter's health and wanted to know...der. He says: "Believe me, I've checked it out t...
Other Medicine News:Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 2Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 3Health News:Novel genetic blood test 2
(Date:10/6/2008)...llaborate to Improve Patient Safety, WASHINGTON, ...lege of,Cardiology in collaboration with the Ameri...eart Association today released consensus guidelin...risk of ulcers and,gastrointestinal (GI) bleeding ...y drugs (NSAIDs) along with antiplatelet agents., ...
(Date:10/6/2008)...ICADE Therapy is More Likely to Induce Steroid-F...andard Immunomodulator, Azathi...a presented for the first time,from the Phase 3b S...unomodulators and Biologic Therapy (SONIC) may pro...ients with moderate to severe Crohn,s disease.,Acc...
(Date:10/6/2008)...e to severe patients achieved endoscopic,response ...sion at Week 10,in data from a 54-week open-label ...nterology (ACG) Annual Scientific Meeting, ORLAND...d data from a,large, prospective study investigati...with a biologic compound. The data presented at th...
(Date:10/6/2008)...ate 6 Weeks of Radiation Therapy -, Event: Watch S...ednesday, October 22, 2008, 3 - 4 p.m. by visit...ON, Va., Oct. 6 / Questions raced thr...breast cancer in May. Would she have the,tumor rem...chemotherapy?, , To view the Multimedia News Rel...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference 10071 1Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics 10067 1Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics 10067 2Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics 10067 3Global Sales Veteran Jack McGovern Joins MediKeeper 10065 1Global Sales Veteran Jack McGovern Joins MediKeeper 10065 2AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors Out of the Closet 26 AHF Pharmacy 10061 1AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors Out of the Closet 26 AHF Pharmacy 10061 2AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors Out of the Closet 26 AHF Pharmacy 10061 3
...e/ -- Southern,Research Institute, a not-for-profi...earch in the areas of preclinical drug,discovery a...tists,will be delivering one oral presentation and...ciation for Cancer Research,(AACR) Annual Meeting,... Roy of Southern Research will be presenting new,d...
...WSWIRE) -- New data,presented at ECCMID highlight ...f Basilea,s (SWX:BSLN) two late-stage,drug candida...ed,both for ceftobiprole, the first anti-MRSA broa..., and for isavuconazole, a,novel azole for the tre...her data on their respective breadths of spectrum,...
Other Medicine Technology:Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 2Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7